Marchi E - Search Results

1

A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.

Cellai L, Cerrini S, Segre A, Battistoni C, Cossu G, Mattogno G, Brufani M, Marchi E. Cellai L, et al. Among authors: marchi e. Mol Pharmacol. 1985 Jan;27(1):103-8. Mol Pharmacol. 1985. PMID: 3965922

2

Structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives.

Cellai L, Cerrini S, Segre AL, Battistoni C, Cossu G, Mattogno G, Brufani M, Marchi E, Venturini AP. Cellai L, et al. Among authors: marchi e. Farmaco. 1989 Feb;44(2):97-107. Farmaco. 1989. PMID: 2775416

3

The synthesis of 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives.

Brufani M, Cellai L, Marchi E, Segre A. Brufani M, et al. Among authors: marchi e. J Antibiot (Tokyo). 1984 Dec;37(12):1611-22. doi: 10.7164/antibiotics.37.1611. J Antibiot (Tokyo). 1984. PMID: 6526730 Free article.

4

4-Deoxypyrido[1',2':1,2]imidazo[5,4-c]rifamycin SV derivatives. A new series of semisynthetic rifamycins with high antibacterial activity and low gastroenteric absorption.

Marchi E, Montecchi L, Venturini AP, Mascellani G, Brufani M, Cellai L. Marchi E, et al. J Med Chem. 1985 Jul;28(7):960-3. doi: 10.1021/jm00145a020. J Med Chem. 1985. PMID: 4009619

5

X-ray crystal structure of 4-deoxy-3'-bromopyrido[1',2'-1,2]imidazo[5,4-c]rifamycin S.

Brufani M, Cellai L, Cerrini S, Fedeli W, Marchi E, Segre A, Vaciago A. Brufani M, et al. Among authors: marchi e. J Antibiot (Tokyo). 1984 Dec;37(12):1623-7. doi: 10.7164/antibiotics.37.1623. J Antibiot (Tokyo). 1984. PMID: 6549316 Free article.

6

[New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV].

Marchi E, Brufani M, Bellomo P. Marchi E, et al. G Ital Chemioter. 1979 Jan-Dec;26(1-2):207-12. G Ital Chemioter. 1979. PMID: 554811 Italian. No abstract available.

7

Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins.

Bellomo P, Marchi E, Mascellani G, Brufani M. Bellomo P, et al. Among authors: marchi e. J Med Chem. 1981 Nov;24(11):1310-4. doi: 10.1021/jm00143a010. J Med Chem. 1981. PMID: 7310806

8

Synthesis and antibacterial activity of some derivatives of tolypomycinone. Relationship between structure and activity in ansamycins.

Bellomo P, Brufani M, Marchi E, Mascellani G, Melloni W, Montecchi L, Stanzani L. Bellomo P, et al. Among authors: marchi e. J Med Chem. 1977 Oct;20(10):1287-91. doi: 10.1021/jm00220a012. J Med Chem. 1977. PMID: 333113

9

Rifaximin (L/105), a new topical intestinal antibiotic: pharmacokinetic study after single oral administration of 3H-rifaximin to rats.

Cellai L, Colosimo M, Marchi E, Venturini AP, Zanolo G. Cellai L, et al. Among authors: marchi e. Chemioterapia. 1984 Dec;3(6):373-7. Chemioterapia. 1984. PMID: 6529779

10

Synthesis of 2-hydroxyacetyl-7-acetyl-xanthone, a new xanthone derivative endowed with antianaphylactic, analgesic, and antiinflammatory activities.

Bianco A, Passacantilli P, Righi G, Brufani M, Cellai L, Marchi E, Milani MR. Bianco A, et al. Among authors: marchi e. Farmaco. 1989 Jun;44(6):547-54. Farmaco. 1989. PMID: 2803446

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

414 results

Search Page

Filters